Serum amyloid A may be associated with hydatidiform mole

Authors : Nazlı Topfedaisi Özkan, Meryem Kuru Pekcan, Gülnur Özakşit, Ibrahim Yalçın, Arzu Kösem, Özcan Erel, Aytekin Tokmak, Mehmet Mutlu Meydanlı

Pages : 721-724

View : 97 | Download : 154

Publication Date : 2024-01-03

Article Type : Research Paper

Abstract :Hydatidiform mole (HM) is a gestational trophoblastic disease. Potential risk factors are advanced maternal age, reproductive factors, oral contraceptive use, history of gestational trophoblastic disease, oxidative stress, and other environmental factors. Serum amyloid A (SAA) protein has an important role in acute phase response but also associated with pathologic fibril formation in chronic inflammation. The aim of the current study is to determine the relationship between maternal SAA levels in patients with both complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM), and to examine possible role in the disease in pathogenesis. Fifty healthy pregnant women in the first trimester of pregnancy with completely normal pregnancy follow-up, and 50 patients who were diagnosed with HM, who were also in the first trimester of pregnancy included to the study. There was no difference between patients and control group according to body mass index (BMI), gravidity, parity, number of living children, number of miscarriage, level of blood TSH, and hemoglobin level between two groups. SAA levels in patients with HM were significantly higher than those in healthy controls. This may be an important underexplored pathway mediating the relationship between oxidative stress and abnormal placental proliferation.
Keywords : Hydatidiform mole

ORIGINAL ARTICLE URL